⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1956799 | 0.74 | KDM4E (0.44) | — | |
| SCHEMBL8880726 | 0.74 | — | — | |
| SCHEMBL4856818 | 0.74 | KDM4E (0.44) | — | |
| SCHEMBL4856814 | 0.74 | KDM4E (0.44) | — | |
| SCHEMBL1358143 | 0.73 | — | — | |
| SCHEMBL1358140 | 0.73 | — | — | |
| SCHEMBL6194847 | 0.73 | — | — | |
| SCHEMBL3667831 | 0.71 | — | — | |
| SCHEMBL87987 | 0.71 | — | — | |
| SCHEMBL7607430 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2414 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4393909-A1 | HYDANTOIN COMPOUND AND MEDICAL USE THEREOF | Harbin Medisan Pharmaceutical Co., LTD. (CN) | 2024-07-03 | — | — | EP | claimed |
| EP-4378931-A1 | TRIAZOLONE COMPOUND AND MEDICINAL USE THEREOF | Harbin Medisan Pharmaceutical Co., LTD. (CN) | 2024-06-05 | — | — | EP | claimed |
| EP-4373825-A1 | NITRILE SUMO INHIBITORS AND USES THEREOF | Suvalent Therapeutics, Inc. (US) | 2024-05-29 | — | — | EP | claimed |
| EP-4373835-A1 | MACROCYLIC IMMUNOMODULATORS | Bristol-Myers Squibb Company (US) | 2024-05-29 | — | — | EP | claimed |
| WO-2023225661-A1 | MACROCYCLIC IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-23 | — | — | WO | claimed |
| US-20230303584-A1 | 4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDINE SUMO INHIBITORS AND USES THEREOF | CIT THERAPEUTICS LLC | 2023-09-28 | — | — | US | claimed |
| EP-3388433-B1 | PHTHALAZINE DERIVATIVES, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHANGHAI SIMR BIOTECH CO LTD (CN) | 2023-08-30 | — | — | EP | claimed |
| WO-2023138302-A1 | HYDANTOIN COMPOUND AND MEDICAL USE THEREOF | 哈尔滨三联药业股份有限公司 | 2023-07-27 | — | — | WO | claimed |
| EP-3632443-B1 | ANTI-TUMOR EFFECT POTENTIATOR USING A BIPHENYL COMPOUND | TAIHO PHARMACEUTICAL CO LTD (JP) | 2023-06-07 | — | — | EP | claimed |
| CN-115894379-A | Hydantoin compound and medical application thereof | 中国药科大学 | 2023-04-04 | — | — | CN | claimed |
| WO-1984000547-A1 | FLUORALKYLATEDCARBAPENEM DERIVATIVES | SANDOZ AG (AT) | 1984-02-16 | — | — | WO | claimed |
| EP-0060612-A1 | Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives | BEECHAM GROUP PLC (GB) | 1982-09-22 | — | — | EP | claimed |
| US-4337061-A | NITRO DYES IN AQUEOUS SOLUTION | SOCIETE ANONYME DITE: L'OREAL (FR) | 1982-06-29 | — | — | US | claimed |
| US-4315855-A | Monoazo disperse dyes containing a nitrophenyl group and a homophthalimide group | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |
| US-4311478-A | HAIR DYES | L'OREAL (FR) | 1982-01-19 | — | — | US | claimed |
| EP-0041768-A2 | Beta-lactam compounds, their preparation and use | BEECHAM GROUP PLC (GB) | 1981-12-16 | — | — | EP | claimed |
| US-4200432-A | HAIR DYES | L'OREAL (FR) | 1980-04-29 | — | — | US | claimed |
| US-4123607-A | BACTERICIDES | AMERICAN CYANAMID COMPANY (US) | 1978-10-31 | — | — | US | claimed |
| US-3998801-A | MONOAZO DYES; POLYAMIDES; RED TO VIOLET SHADES | EASTMAN KODAK COMPANY (US) | 1976-12-21 | — | — | US | claimed |
| US-3957766-A | BACTERIOSTATS, BACTERICIDES | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-05-18 | — | — | US | claimed |